Clinical trial
A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With…
NCT00047645 · InterMune, Industry · Completed
Key facts
| NCT number | NCT00047645 |
|---|---|
| Title | A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis |
| Lead sponsor | InterMune, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis |
| Intervention type | Drug |
| Interventions | Interferon-gamma 1b |
| Enrollment | 330 |
| Start date | Apr 1, 2000 |
| Completion | Dec 1, 2002 |
| First posted | Oct 11, 2002 |
| Last update posted | Nov 2, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: